One in Three American GLP-1 Users Are Drinking Less

GLP-1s are doing something to alcohol that no other category is seeing. Most effects fade when the drug stops. Food noise comes back. Appetite comes back. But 23% of current users say alcohol became less appealing as an unexpected side effect, and among people who've stopped taking the medication, that figure holds at 24%. The lower interest in drinking outlasts the prescription, and it's spreading: considerers are drinking less at almost the same rate as current users.

This report breaks down what that means for alcohol. Why the pullback persists after treatment ends, why non-alcoholic alternatives aren't absorbing the demand, and where the opportunity opens up for new products, occasions and experiences.

• The persistence effect, and why alcohol breaks the pattern of every other GLP-1 side effect

• A new drinking baseline: current users, considerers and lapsed users are all drinking less

• Why non-alcoholic alternatives aren't inheriting the pullback

• The dinner-party shift: non-users in GLP-1 households are 1.8x more likely to notice friends drinking less

• Where the category goes next, and how to test against it

• The persistence effect, and why alcohol breaks the pattern of every other GLP-1 side effect

• A new drinking baseline: current users, considerers and lapsed users are all drinking less

• Why non-alcoholic alternatives aren't inheriting the pullback

• The dinner-party shift: non-users in GLP-1 households are 1.8x more likely to notice friends drinking less

• Where the category goes next, and how to test against it